Plante Moran Financial Advisors, LLC Takeda Pharmaceutical CO LTD Transaction History

Plante Moran Financial Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$12.42 - $15.62 $695 - $874	-56 Reduced 37.09%	95 $1,000
Q2 2021 Aug 10, 2021	SELL	$16.55 - $18.64 $2,747 - $3,094	-166 Reduced 52.37%	151 $3,000
Q3 2020 Nov 12, 2020	BUY	$17.1 - $19.19 $2,838 - $3,185	166 Added 109.93%	317 $6,000
Q1 2020 May 07, 2020	SELL	$13.02 - $20.31 $6,809 - $10,622	-523 Reduced 77.6%	151 $2,000
Q4 2019 Feb 14, 2020	SELL	$16.88 - $20.83 $6,988 - $8,623	-414 Reduced 38.05%	674 $13,000
Q3 2019 Nov 13, 2019	BUY	$16.15 - $17.99 $12,823 - $14,284	794 Added 270.07%	1,088 $18,000
Q2 2019 Aug 13, 2019	SELL	$16.58 - $20.49 $1,376 - $1,700	-83 Reduced 22.02%	294 $5,000
Q1 2019 May 13, 2019	BUY	$16.7 - $21.52 $6,295 - $8,113	377 New	377 $8,000

337

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Plante Moran Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Plante Moran Financial Advisors, LLC with notifications on news.